复杂胆石病内镜下括约肌切开术后胆囊切除术的影响
该研究对65岁及以上因胆总管结石、上行性胆管炎或胆石性胰腺炎行内镜下括约肌切开术(ES)的患者进行校正分析,比较术后行与未行胆囊切除术的临床结局。ES联合胆囊切除术组复发胆总管结石、上行性胆管炎和胆石性胰腺炎的OR分别为0.38、0.28和0.35(P均<0.001),且严重术后并发症未增多。
要点
- 在≥65岁患者中,ES后行胆囊切除术与复发胆总管结石风险降低相关(OR 0.38)。
- ES后胆囊切除术与复发上行性胆管炎(OR 0.28)和胆石性胰腺炎(OR 0.35)风险降低相关。
- 心肌梗死、肺栓塞和肺炎等严重术后并发症在胆囊切除术组未更常见。
核心结论
- 在老年患者(包括有严重合并症者)中,内镜下括约肌切开术后行胆囊切除术与复发并发症的显著且具有临床重要意义的降低相关,且该获益似乎未被手术并发症所抵消。
研究设计与样本
- 对65岁及以上因胆总管结石、上行性胆管炎或胆石性胰腺炎行内镜下括约肌切开术的患者进行校正分析,比较术后行与未行胆囊切除术者的临床结局及不良事件。
主要发现
- 仅ES组39.3%的患者发生复发性并发症,ES联合胆囊切除术组为18.0%。
- 多变量回归校正合并症后,与仅ES相比,ES联合胆囊切除术与复发胆总管结石风险降低相关(OR 0.38,95%CI 0.34-0.42,P<0.001)。
- 多变量回归校正合并症后,与仅ES相比,ES联合胆囊切除术与复发上行性胆管炎风险降低相关(OR 0.28,95%CI 0.23-0.34,P<0.001)。
- 多变量回归校正合并症后,与仅ES相比,ES联合胆囊切除术与复发胆石性胰腺炎风险降低相关(OR 0.35,95%CI 0.24-0.49,P<0.001)。
- 该获益在倾向评分校正后、≥75岁患者中以及合并癌症、心力衰竭和肝病等主要合并症者中仍然存在。
关键数值与推荐
- 仅ES组复发性并发症发生率为39.3%,ES联合胆囊切除术组为18.0%。
- 复发胆总管结石:ES联合胆囊切除术 vs 仅ES的OR 0.38(95%CI 0.34-0.42,P<0.001)。
- 复发上行性胆管炎:ES联合胆囊切除术 vs 仅ES的OR 0.28(95%CI 0.23-0.34,P<0.001)。
- 复发胆石性胰腺炎:ES联合胆囊切除术 vs 仅ES的OR 0.35(95%CI 0.24-0.49,P<0.001)。
临床怎么用
- 原文未据此给出推荐。
局限性
- 原文未报告局限性。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
OBJECTIVES: Cholecystectomy after endoscopic sphincterotomy (ES) is associated with improved outcomes compared to ES alone, however randomized trials have included mainly fit surgical candidates. Our objective was to assess the impact of cholecystectomy after ES among elderly patients, in whom the perceived risks of surgery may be increased and the prevailing bias may be to defer cholecystectomy. METHODS: We performed adjusted analyses comparing clinical outcomes in patients ≥65 years of age who did and did not undergo follow-up cholecystectomy after endoscopic sphincterotomy for choledocholithiasis, ascending cholangitis, or gallstone pancreatitis. We also compared adverse events between the two groups. RESULTS: In the ES alone group, 39.3% of patients experienced a recurrent complication compared with 18.0% in the ES and cholecystectomy group. After adjusting for comorbidities using multivariable regression, cholecystectomy in addition to ES was associated with a reduced risk of recurrent choledocholithiasis (OR 0.38, 95%CI 0.34-0.42, P<0.001), ascending cholangitis (OR 0.28, 95%CI 0.23-0.34, P<0.001), and gallstone pancreatitis (OR 0.35, 95%CI 0.24-0.49, P<0.001) compared to ES alone. This benefit was preserved after propensity score adjustment, in patients ≥75 years of age, and in those with major comorbidities including cancer, heart failure, and liver disease. Serious post-operative complications such as myocardial infarction, pulmonary embolism, and pneumonia were not more common in the cholecystectomy group. CONCLUSIONS: Among older patients, including those with serious comorbidities, cholecystectomy after endoscopic sphincterotomy was associated with a significant and clinically important reduction in recurrent complications compared to sphincterotomy alone. This benefit did not appear to be outweighed by surgical complications, highlighting the importance of cholecystectomy, even in elderly patients whose lifespans may be limited by unrelated conditions.
引用
- Elmunzer BJ, Noureldin M, Morgan KA, et al. The Impact of Cholecystectomy After Endoscopic Sphincterotomy for Complicated Gallstone Disease. Am J Gastroenterol. 2017. PMID: 28809384. doi:10.1038/ajg.2017.247
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。